ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU)
CUSIP: 005083100
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 23,165,208
- Total 13F shares
- 12,026,097
- Share change
- +808,239
- Total reported value
- $80,455,749
- Price per share
- $6.69
- Number of holders
- 42
- Value change
- +$5,410,880
- Number of buys
- 21
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 005083100?
CUSIP 005083100 identifies ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 005083100:
Top shareholders of ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BIOS Fund I, LP |
13D/G
|
AARON G.L. FLETCHER |
50%
|
10,267,232
|
$112,734,207 | +$1,733,259 | 27 Jun 2025 | |
| Aaron G.l. Fletcher |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
10,329,768
mixed-class rows
|
$111,175,297 | +$499,996 | 27 Jun 2025 | |
| Bios Equity COF, LP |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
10,314,768
mixed-class rows
|
$111,175,297 | +$499,996 | 27 Jun 2025 | |
| Leslie W. Kreis |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
10,314,768
mixed-class rows
|
$111,175,297 | +$499,996 | 27 Jun 2025 | |
| BIOS Capital Management, LP |
13F
|
Company |
43%
|
9,965,079
|
$60,886,633 | — | 30 Jun 2025 | |
| Voss Capital, LP |
13F
|
Company |
1.2%
|
286,140
|
$1,748,315 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
264,464
|
$1,615,875 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.84%
|
195,452
|
$1,194,212 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
118,050
|
$721,284 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
85,694
|
$523,591 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
37,334
|
$228,111 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
31,414
|
$191,940 | — | 30 Jun 2025 | |
| NORTHWESTERN UNIVERSITY |
13F
|
Company |
0.12%
|
27,778
|
$169,722 | — | 30 Jun 2025 | |
| Gleason Group, Inc. |
13F
|
Company |
0.08%
|
19,028
|
$116,261 | — | 30 Jun 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.08%
|
18,705
|
$114,288 | — | 30 Jun 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.08%
|
18,518
|
$113,145 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.07%
|
17,200
|
$105,092 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
15,292
|
$93,434 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
14,765
|
$90,214 | — | 30 Jun 2025 | |
| SFMG, LLC |
13F
|
Company |
0.06%
|
14,550
|
$88,901 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
12,796
|
$78,184 | — | 30 Jun 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.04%
|
10,365
|
$68,409 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
10,439
|
$63,782 | — | 30 Jun 2025 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0.04%
|
10,000
|
$61,100 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
9,082
|
$55,485 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
7,740
|
$47,291 | — | 30 Jun 2025 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0.03%
|
6,250
|
$38,188 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
5,243
|
$32,035 | — | 30 Jun 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
3,189
|
$19,485 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
2,780
|
$16,986 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,347
|
$14,340 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
2,089
|
$12,764 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,300
|
$8,000 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,000
|
$6,110 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
905
|
$5,530 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
708
|
$4,326 | — | 30 Jun 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
601
|
$3,672 | — | 30 Jun 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
367
|
$2,242 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
311
|
$1,900 | — | 30 Jun 2025 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
201
|
$1,000 | — | 30 Jun 2025 | |
| Sterling Capital Management LLC |
13F
|
Company |
0%
|
14
|
$86 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
13
|
$79 | — | 30 Jun 2025 | |
| Bios Clinical Opportunity Fund, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
231,377
|
— | — | 12 Aug 2024 | |
| Bios 2024 Co-Invest, LP |
3/4/5
|
Director, Member of 10% Group |
—
class O/S missing
|
125,000
|
— | — | 14 Aug 2024 | |
| Dan Zabrowski |
3/4/5
|
Director |
—
mixed-class rows
|
106,348
mixed-class rows
|
— | — | 22 May 2025 | |
| Amy L. Ronneberg |
3/4/5
|
Director |
—
mixed-class rows
|
45,000
mixed-class rows
|
— | — | 22 May 2025 | |
| Jason A. Keyes |
3/4/5
|
Director |
—
mixed-class rows
|
45,000
mixed-class rows
|
— | — | 22 May 2025 | |
| Roger Sawhney |
3/4/5
|
Director |
—
mixed-class rows
|
45,000
mixed-class rows
|
— | — | 22 May 2025 |
Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) as of Q3 2025
As of 30 Sep 2025,
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,026,097 shares.
The largest 10 holders included
BIOS Capital Management, LP, Voss Capital, LP, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, STATE STREET CORP, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Gleason Group, Inc., and SFMG, LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
38
Q3 2025 holders
42
Holder diff
4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.